Sep 25, 2024

Featuring a slide presentation and related discussion from Dr Tiffany A Traina, including the following topics:

• Extended follow-up with pembrolizumab/chemotherapy for patients with previously untreated PD-L1-positive metastatic triple-negative breast cancer (mTNBC) (0:00)
• ASCENT trial: Survival advantage...

Sep 25, 2024

Featuring an interview with Dr Tiffany A Traina, including the following topics:

• Choice of chemotherapy to combine with first-line pembrolizumab for metastatic triple-negative breast cancer (mTNBC) (0:00)
• Ongoing investigations of androgen receptor-targeting agents for metastatic breast cancer (mBC) (8:37)
• Efficacy and...

Sep 20, 2024

Featuring slide presentations and related discussion from Dr Lipika Goyal, Dr James J Harding, Dr Milind Javle and Dr Robin K (Katie) Kelley, including the following topics:

• Current Role of Immunotherapeutic Strategies for Advanced Biliary Tract Cancers (BTCs) — Dr Kelley (0:00)
• Case: A man in his late 60s with...

Sep 19, 2024

Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors | Faculty Presentation 2: Later-Line Treatment for Advanced NETs — Pamela Kunz, MD

CME information and select publications

Sep 19, 2024

Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors | Faculty Presentation 1: First-Line Therapy for Advanced Neuroendocrine Tumors (NETs) — Simron Singh, MD, MPH

CME information and select...